Knowledge Center
Patent / Aug 04, 2022
Inhaled ivermectin
Source:
US 20220241307
The present invention contemplates the use of inhaled ivermectin for use in various viruses and parasitic infections (treatment and/or prophylaxis) that are present or manifest in the lungs or respiratory tract. Exemplary dosing, formulations, devices, and processing techniques are also disclosed herein.
Ìý
Also in the Knowledge Center
Scientific Article
/ May 06, 2021
Dry powder inhaler formulation of Cu,Zn-superoxide dismutase by spray drying: A proof-of-concept
Read more
Scientific Article
/ Sep 25, 2021
Dry powder inhaler formulation comparison: Study of the role of particle deposition pattern and dissolution
Read more
Scientific Article